Quince Therapeutics advances Ataxia-Telangiectasia treatment with innovative AIDE platform, insider support, and NEAT Phase 3 ...

Worse, Ciattarelli called Trump a “charlatan” in 2015 and said he was “not fit” to serve in the Oval Office. The president, ...

SIRI's monopoly in US satellite radio, stable EPS, and extremely cheap valuation make it attractive, with intrinsic value ...

Inside the quiet rebellion of women upgrading their bodies - IN FOCUS: Faced with a medical establishment that doesn’t serve ...

The Bay Area's biotech industry faces an uncertain future after 50 years. But industry leaders see a history of resilience ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.

Pathos AI, a leading AI-driven biotech company applying cutting-edge artificial intelligence to drug development, today announced its $365 million Series D financing, bringing its post-money valuation ...

Transaction To Accelerate Terra Innovatum’s Pathway to Commercialization of Groundbreaking Micro-Modular Nuclear Technology ...

Scientists at the McGovern Institute and the Broad Institute of MIT and Harvard have reengineered a compact RNA-guided enzyme ...

A study has found that an ancient protein motif that binds to nucleic acids is functionally "ambidextrous." This means that ...

Supreme Court Wrestles With Judges’ Power to Freeze Government Actions Nationwide The Supreme Court heard arguments in a case with potentially major implications for the power of federal judges ...

A new gene editor takes advantage of CRISPR-associated proteins to insert whole genes into the genome, scientists report.